Search

everythinglearnresearchcommunity

for

Search:↓

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

The new formulation greatly improved quercetin absorption in rats.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Inner city teens had high retention rates for the contraceptive implant, especially those with a history of abortion.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Estetrol may help prevent hair loss and support hair growth in women.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

17α-estradiol extends lifespan and improves metabolism in male mice through the estrogen receptor α.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Estetrol may help prevent hair loss and promote hair growth in women.

The FDA rejected a testosterone drug again due to safety concerns.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Monitoring for adverse effects in clinical treatments is crucial.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.